Trial intelligence / Profile preview

Rebamipide in Chronic Gastritis

NCT00996788Phase 3Completed

Sponsor
Otsuka Holdings
Start
Oct 2007
Primary completion
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of rebamipide in chronic gastritis, dyspepsia, sponsored by Otsuka Holdings. Started Oct 2007; status: completed.

02

Drugs

rebamipide
03

Conditions

chronic gastritisdyspepsia

Beyond the preview

Go deeper on NCT00996788.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00996788.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call